Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications. Read More > May 3, 2017
1001. Neurocognitive Effects of Repeated Ketamine Infusions in Co-Occurring Posttraumatic Stress Disorder and Treatment-Resistant Depression Read More > April 29, 2017
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial Read More > April 28, 2017
Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders Read More > April 26, 2017
Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment Read More > April 23, 2017
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Read More > April 19, 2017
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity Read More > April 11, 2017
Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain Read More > April 7, 2017
A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial Read More > April 4, 2017
Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression Read More > April 1, 2017
